Aclaris Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Aclaris Therapeutics, a clinical-stage biopharmaceutical company listed on NASDAQ under the symbol ACRS, announced their participation in two upcoming investor conferences. Dr. Neal Walker, President and CEO, will present at the H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021, and at the 2021 Cantor Virtual Global Healthcare Conference on September 27, 2021. Both events will include opportunities for virtual one-on-one meetings. Webcasts of the presentations will be available on the Aclaris website for 30 days.

WAYNE, Pa., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that management will participate in the following upcoming investor conferences:

• H.C. Wainwright 23rd Annual Global Investment Conference. On Monday, September 13, 2021 at 7:00 a.m. ET, Dr. Neal Walker, the President and CEO of Aclaris, will virtually present a company overview. Management will be available September 13th throughout the day for virtual one-on-one meetings.
  
  
• 2021 Cantor Virtual Global Healthcare Conference. On Monday, September 27, 2021 at 9:20 a.m. ET, Dr. Walker will participate in a virtual fireside chat. Management will be available September 27th throughout the day for virtual one-on-one meetings.
  

A live webcast of the presentation and fireside chat may be accessed through the “Events” page of the “Investors” section of Aclaris’ website, www.aclaristx.com. Each webcast will be archived for at least 30 days on the Aclaris website.

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation. For additional information, please visit www.aclaristx.com.

Aclaris Contact

investors@aclaristx.com 

FAQ

What investor conferences is Aclaris Therapeutics participating in September 2021?

Aclaris Therapeutics is participating in the H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021, and the 2021 Cantor Virtual Global Healthcare Conference on September 27, 2021.

Who will represent Aclaris at the upcoming investor conferences?

Dr. Neal Walker, the President and CEO of Aclaris Therapeutics, will represent the company at both investor conferences.

What details are available for the H.C. Wainwright investor conference?

At the H.C. Wainwright conference on September 13, 2021, Dr. Walker will present a company overview at 7:00 a.m. ET and will be available for virtual one-on-one meetings throughout the day.

When will Aclaris' presentations be accessible online?

The webcasts of Aclaris' presentations will be accessible through the 'Events' page on their website and archived for at least 30 days.